Novo Nordisk A/S (NVO)

Growth

Revenue 5Y6.43%
Revenue 3Y9.29%
EPS 5Y6.42%
EPS 3Y8.63%
Dividend 5Y-0.43%
Dividend 3Y5.41%

Capital Efficiency

ROIC63.38%
ROE73.26%
ROA21.75%
ROTA21.75%

Capital Structure

Market Cap297.55B
EV295.05B
Cash28.46B
Current Ratio0.92
Debt/Equity0.68
Net Debt/EBITDA-0.03
Show More

Segments & KPIs

Select a metric from the list below to chart it

Dec '12
Dec '14
Dec '16
Dec '18
Dec '20
Dec '22
Segments & KPIs
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Total NAO Revenue (DKK M)
Total NAO Revenue (DKK M) % Chg.
US Revenue (DKK M)
US Revenue (DKK M) % Chg.
Other NAO Revenue (DKK M)
Other NAO Revenue (DKK M) % Chg.
EMEA Revenue (DKK M)
EMEA Revenue (DKK M) % Chg.
China Revenue (DKK M)
China Revenue (DKK M) % Chg.
Rest of World Revenue (DKK M)
Rest of World Revenue (DKK M) % Chg.
Diabetes & Obesity Care Revenue (DKK M)
Diabetes & Obesity Care Revenue (DKK M) % Chg.
Rare Disease Revenue (DKK M)
Rare Disease Revenue (DKK M) % Chg.
Diabetes & Obesity Care Operating Profit (DKK M)
Diabetes & Obesity Care Operating Profit (DKK M) % Chg.
Rare Disease Operating Profit (DKK M)
Rare Disease Operating Profit (DKK M) % Chg.